Product Information
XCOPRI 100 MG TABLET is a brand product labeled by SK Life Science, Inc., priced at $39.8743 per EA under NDC 71699010030. Its NADAC has been published 249 times since Sep 22, 2021.
Strength
100 mg/1
Manufacturer
SK Life Science, Inc.NDC
71699010030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CENOBAMATEApproval Type
New Drug (NDA)
FDA Application
NDA212839On Market Since
3/12/2020
Pharmacological Classes
Price Statistics
The NADAC for XCOPRI 100 MG TABLET has been published 249 times since Sep 22, 2021, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.8743 per EA |
|---|---|
| All-time high | $39.9308 (May 13, 2026) |
| All-time low | $32.9863 (Sep 22, 2021) |
| 52-week high | $39.9308 |
| 52-week low | $38.7318 |
| Median price | $37.7007 |
| Average price | $36.6583 |
| Largest weekly change | +6.0% (Jan 3, 2024) |
| Weeks tracked | 249 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cenobamate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XCOPRI 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XCOPRI 100 MG TABLET, manufactured by SK Life Science, Inc., is $39.8743 per EA (NDC 71699010030), effective Jun 24, 2026.
How has the price of XCOPRI 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for XCOPRI 100 MG TABLET has risen 20.9%. It has been tracked across 249 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for XCOPRI 100 MG TABLET?
Since Sep 22, 2021, the NADAC for XCOPRI 100 MG TABLET has ranged from a low of $32.9863 (Sep 22, 2021) to a high of $39.9308 (May 13, 2026), with a median of $37.7007 per EA.
Are there cheaper alternatives to XCOPRI 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XCOPRI 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures XCOPRI 100 MG TABLET?
XCOPRI 100 MG TABLET (NDC 71699010030) is labeled by SK Life Science, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification